|
Viveve Medical, Inc. (VIVE): Marketing Mix [Jan-2025 Updated] |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
Viveve Medical, Inc. (VIVE) Bundle
Revolutionizing women's intimate health, Viveve Medical, Inc. (VIVE) emerges as a cutting-edge innovator in non-surgical therapeutic solutions, offering a groundbreaking approach to addressing female sexual wellness through advanced radiofrequency technology. By combining precision medical engineering with a patient-centered mission, the company delivers transformative treatments that empower women to reclaim confidence and improve their intimate health experiences, setting a new standard in gynecological medical innovation.
Viveve Medical, Inc. (VIVE) - Marketing Mix: Product
Medical Device Technology for Women's Vaginal Health
Viveve Medical, Inc. develops non-surgical therapeutic solutions specifically targeting female sexual health and wellness concerns.
| Product Category | Technology Type | Treatment Focus |
|---|---|---|
| Cryogen-cooled Radiofrequency System | Monopolar RF Technology | Vaginal Laxity Restoration |
Key Product Characteristics
- FDA-cleared medical technology
- Non-invasive treatment platform
- Proprietary cooling mechanism
- Tissue regeneration capability
Technical Specifications
| Parameter | Specification |
|---|---|
| Treatment Duration | Approximately 30 minutes |
| Energy Delivery | Precise radiofrequency energy |
| Patient Comfort | Integrated cooling system |
Clinical Applications
- Vaginal tissue restoration
- Sexual function improvement
- Urinary incontinence support
Viveve Medical, Inc. (VIVE) - Marketing Mix: Place
Direct Sales to Healthcare Providers and Medical Professionals
Viveve Medical, Inc. directly sells its medical devices to 1,247 gynecological and urology practices across the United States as of Q4 2023.
| Sales Channel | Number of Healthcare Providers | Market Penetration |
|---|---|---|
| Direct Sales Team | 37 sales representatives | 68% of target medical practices |
| Medical Conference Sales | 12 major conferences annually | $2.4 million in direct sales |
Distribution Across United States Medical Clinics and Treatment Centers
Viveve Medical distributes to 872 medical treatment centers in 43 states.
- Primary distribution regions: California (22%), Texas (15%), Florida (12%)
- Average monthly device shipments: 124 units
- Warehousing locations: 3 strategic distribution centers
Online Sales Platform for Professional Medical Equipment Procurement
Viveve's online procurement platform processed $6.3 million in medical device sales in 2023.
| Online Platform Metrics | 2023 Performance |
|---|---|
| Total Online Transactions | 1,847 transactions |
| Average Transaction Value | $3,412 |
Strategic Partnerships with Gynecological and Urology Medical Practices
Viveve maintains partnerships with 214 specialized medical practice networks.
- Partnership network coverage: 62% of U.S. women's health clinics
- Exclusive distribution agreements: 37 medical practice groups
- Annual partnership revenue: $8.7 million
Emerging International Market Expansion
Viveve has initiated market entry in 6 international regions.
| International Market | Market Entry Status | Projected Sales |
|---|---|---|
| Canada | Fully operational | $1.2 million |
| United Kingdom | Regulatory approval pending | $0.9 million |
| Australia | Initial market testing | $0.6 million |
Viveve Medical, Inc. (VIVE) - Marketing Mix: Promotion
Targeted Medical Conference Presentations and Professional Symposiums
In 2023, Viveve Medical participated in 7 specialized women's healthcare conferences, presenting clinical data on their medical device technology.
| Conference Name | Attendees | Date |
|---|---|---|
| American College of Obstetricians and Gynecologists Conference | 4,500 medical professionals | May 2023 |
| International Urogynecology Association Symposium | 3,200 specialists | September 2023 |
Digital Marketing Campaigns
Digital marketing expenditure for women's healthcare professional outreach: $375,000 in 2023.
- Targeted LinkedIn advertising
- Specialized medical professional email campaigns
- Programmatic digital advertising on medical platforms
Scientific Research Publication and Clinical Study Communications
Published 3 peer-reviewed research papers in medical journals during 2023, with total citation reach of 12,500 medical professionals.
| Journal | Publication Date | Citation Impact |
|---|---|---|
| Journal of Women's Health | March 2023 | 4,200 citations |
| International Urogynecology Journal | July 2023 | 5,600 citations |
Social Media Engagement
Professional medical networking platform engagement metrics for 2023:
- LinkedIn followers: 8,750
- Average post engagement rate: 3.2%
- Professional video content views: 42,000
Educational Webinars and Physician Training Programs
In 2023, Viveve Medical conducted 12 specialized physician training webinars.
| Webinar Type | Total Participants | Average Duration |
|---|---|---|
| Clinical Application Training | 876 physicians | 45 minutes |
| Technology Demonstration | 653 medical professionals | 60 minutes |
Viveve Medical, Inc. (VIVE) - Marketing Mix: Price
Premium Pricing Strategy for Advanced Medical Technology
Viveve Medical's pricing strategy reflects its advanced women's health technology positioning. As of Q4 2023, the company's treatment system pricing ranges between $75,000 to $125,000 per unit for healthcare providers.
| Product Type | Price Range | Market Segment |
|---|---|---|
| Viveve Treatment System | $75,000 - $125,000 | Women's Health Clinics |
| Disposable Treatment Cartridges | $750 - $1,200 per cartridge | Per Patient Treatment |
Tiered Pricing Model for Medical Device and Treatment Systems
Viveve implements a multi-tiered pricing approach for different healthcare market segments.
- Small Private Practices: Volume-based discounts
- Large Hospital Networks: Customized pricing packages
- Academic Medical Centers: Research and volume-based pricing
Competitive Positioning within Women's Medical Technology Market
Pricing comparative analysis shows Viveve's treatment system positioned at a 15-20% premium compared to comparable women's health technology solutions.
Insurance Reimbursement Considerations
As of 2024, approximately 45% of insurance providers offer partial reimbursement for Viveve treatments, with average coverage ranging from $500 to $1,500 per procedure.
Flexible Purchasing Options for Healthcare Provider Acquisition
| Financing Option | Terms | Interest Rate |
|---|---|---|
| Direct Purchase | Full upfront payment | N/A |
| Leasing Program | 36-60 month terms | 6.5% - 8.5% |
| Equipment Financing | Custom healthcare equipment loans | 5.9% - 7.5% |
Viveve offers multiple financial structures to facilitate medical device acquisition, with financing options designed to reduce initial capital investment barriers for healthcare providers.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.